FDA Law Blog

OCTOBER 8, 2023

Palmer — On Friday, October 6, 2023, DEA announced a second extension of telemedicine flexibilities concerning the prescribing of controlled substances, which were originally set to expire after the end of the COVID-19 pandemic emergency. By Karla L. comments on the two proposed rules.

Telemedicine 64

Telemedicine Relationship IT Mental Health 64

FDA Law Blog

JUNE 8, 2023

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — On May 11, 2023, the U.S. The pandemic also deeply impacted how industry and the government conduct their operations. CDER and CBER CDER and CBER announced they would resume in-person face-to-face (FTF) industry meetings on February 13, 2023.

Relationship 53

Relationship Government Screening Medical 53

FDA Law Blog

MARCH 13, 2024

1.740), stating that: If the applicant for patent term extension was not the marketing applicant before the regulatory agency, then there must be an agency relationship between the patent owner and the marketing applicant during the regulatory review period. 10,544,220 (October 24, 2023) Pursuant to 37 C.F.R. Appendix D. Biogen MA Inc.

Relationship 59

Relationship Provider IT Government 59

GeriPal

MARCH 6, 2025

link] PEACH Good Wishes Program A program that provides meaningful gifts for unhoused individuals who are terminally ill. So we did a podcast on aging and homelessness with Margot Kushel in 2023. They can’t believe it, but we come back again and again and again gently to provide that support. We just hired a nurse.

Healthcare 100

Healthcare IT Community Illness 100

GeriPal

SEPTEMBER 5, 2024

Louise 05:02 Yes, well, I don’t know about 2024, but in 2023, yes, it could happen. And it’s not the same, but it does provide information. Eric 42:11 But how much of it is like Winston Churchill, like, democracy is the worst form of government. Widera and Smith have no relationships to disclose.

Patients 98

Patients IT Patient-Centered Hospital 98

The Clinical Problem Solvers

MAY 2, 2023

[link] CPSolvers: Antiracism in Medicine Series Episode 21 – Psychosocial and Cultural Considerations for Providing Healthcare to Immigrant and Refugee Populations Show Notes by Kiersten T. April 25, 2023 Show Transcript Download CPSolvers App here RLRCPSOLVERS

Healthcare 52

Healthcare Provider Clinical Practice Clinic 52

FDA Law Blog

MAY 26, 2025

Specifically, these are procedures and drugs used in providing what HHS had, until recently, referred to as gender-affirming care. Department of Health & Human Services purporting to provide a comprehensive review of the evidence and best practices for promoting the health of children and adolescents with gender dysphoria.

Manufacturing 59

Manufacturing Provider Medical IT 59